Table 3.
PICU mortality | |||||
---|---|---|---|---|---|
|
|||||
Overall (N = 255) | Survived (N = 225) | Died (N = 30) | Odds ratio (95% CI) | P-value | |
Biomarker trajectory | <.001 | ||||
| |||||
Groups 1–4 | 225 (88%) | 207 (92%) | 18 (60%) | Reference | |
| |||||
Group 5 | 30 (12%) | 18 (8%) | 12 (40%) | 7.03 (2.52, 20.15) | |
| |||||
Age | 6 [2, 12] | 6 [2, 12] | 9 [2, 15] | 1.03 (0.95, 1.11) | 0.469 |
| |||||
PRISM-3 | 8 [3, 15] | 8 [3, 14] | 11 [3, 19] | 1.04 (0.98, 1.09) | 0.186 |
| |||||
Immunocompromised | 66 (26%) | 53 (24%) | 13 (43%) | 1.08 (0.39, 2.76) | 0.872 |
Estimates are based on a multivariable model, adjusting for each of the predictors in this table.
Abbreviations: PRISM, pediatric risk of mortality score.